| Srinivas S Atri, MD | |
|
370 Middletown Blvd, Oxford Square Ste 510, Langhorne, PA 19047-1840 | |
| (215) 750-6566 | |
| (215) 750-7288 |
| Full Name | Srinivas S Atri |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 47 Years |
| Location | 370 Middletown Blvd, Langhorne, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669434460 | NPI | - | NPPES |
| 0009260330012 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD030024E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aria Health Physician Services | 3577467018 | 418 |
News Archive
Health Literacy And Outcomes Among Patients With Heart Failure - This study examines the correlation between health literacy, or the ability to understand basic health information, and the mortality rate among patients with heart failure, which is a condition that "requires self-management and frequent interactions with the health care system."
The pharmaceutical and biotechnology industries face further marketing and sales challenges in 2005 as the fallout from the Vioxx and Celebrex market recall and warning make it increasingly challenging for companies across the industry to reach physicians and consumers with effective campaigns without the distractions of the unfavorable press these recent events have generated.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
Scientists at The Institute of Cancer Research, London, have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps cancer cells survive. The findings could lead to new ways to target the disease.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
Health Literacy And Outcomes Among Patients With Heart Failure - This study examines the correlation between health literacy, or the ability to understand basic health information, and the mortality rate among patients with heart failure, which is a condition that "requires self-management and frequent interactions with the health care system."
The pharmaceutical and biotechnology industries face further marketing and sales challenges in 2005 as the fallout from the Vioxx and Celebrex market recall and warning make it increasingly challenging for companies across the industry to reach physicians and consumers with effective campaigns without the distractions of the unfavorable press these recent events have generated.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
Scientists at The Institute of Cancer Research, London, have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps cancer cells survive. The findings could lead to new ways to target the disease.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Srinivas S Atri, MD Aria Health Physician Services, Po Box 8500-6335, Philadelphia, PA 19178-6335 Ph: (215) 750-6566 | Srinivas S Atri, MD 370 Middletown Blvd, Oxford Square Ste 510, Langhorne, PA 19047-1840 Ph: (215) 750-6566 |
News Archive
Health Literacy And Outcomes Among Patients With Heart Failure - This study examines the correlation between health literacy, or the ability to understand basic health information, and the mortality rate among patients with heart failure, which is a condition that "requires self-management and frequent interactions with the health care system."
The pharmaceutical and biotechnology industries face further marketing and sales challenges in 2005 as the fallout from the Vioxx and Celebrex market recall and warning make it increasingly challenging for companies across the industry to reach physicians and consumers with effective campaigns without the distractions of the unfavorable press these recent events have generated.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
Scientists at The Institute of Cancer Research, London, have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps cancer cells survive. The findings could lead to new ways to target the disease.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
Vincent Michael Figueredo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Dr. Gregory P Zollner, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 240 Middletown Blvd, Ste 200, Langhorne, PA 19047 Phone: 215-757-5772 Fax: 215-757-5494 | |
Dr. John A Volpe, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 234, Langhorne, PA 19047 Phone: 215-750-2911 Fax: 215-750-2917 | |
Ellen Miller, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 825 Town Center Dr, Suite 152, Langhorne, PA 19047 Phone: 215-741-3510 Fax: 215-741-3519 | |
Jonathan Gold, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd, Suite 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Ronald H Fields, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd, Suite 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Fozia Farooqui, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 226, Langhorne, PA 19047 Phone: 215-710-4460 Fax: 215-710-4465 |